Jones Day Continues Expansion of Health Care and Life Sciences Practices with Arrival of Edgar J. Asebey

Thursday, March 12, 2015 - 16:39

Jones Day has announced that Edgar J. Asebey has joined the Firm's Miami Office as a partner in its Health Care and Life Sciences practices. He arrives from Roetzel & Andress in Washington, DC and Fort Lauderdale, where he was the Practice Group Manager for Food & Drug Law.

Mr. Asebey's practice focuses on foods, medical devices, drugs, dietary supplements, and cosmetics and he advises clients in these industries on regulatory, registration, importation, and enforcement matters. He also counsels clients on premarket approval submissions, and on compliance issues associated with the development, manufacture, marketing, and sale of FDA-regulated products. Mr. Asebey is a leading authority on the Food Safety Modernization Act (FSMA) and has lectured in forums in Latin America, Japan, and the U.S. on FSMA's impact on U.S. importers, non-U.S. food exporters, and food companies.

In the medical device area, Mr. Asebey performs FDA regulatory and CMS reimbursement due diligence on behalf of venture capital firms prior to their making investment commitments, and for private companies considering M&A activities. He also works with clients on the preparation of various FDA submissions, which include 510(k) premarket notifications, food additive petitions, GRAS self-affirmations and notifications, and product listing registrations.

An active speaker and writer on FDA and life science matters, Mr. Asebey has, since 2011, delivered more than 30 presentations on the impact of the Food Safety Modernization Act (FSMA) and related topics.